<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03112122</url>
  </required_header>
  <id_info>
    <org_study_id>BME-TARGET</org_study_id>
    <nct_id>NCT03112122</nct_id>
  </id_info>
  <brief_title>Study for the Treatment of the Bone Marrow Edema:Core Decompression VS Bone Marrow Concentrate (BMC) VS Bone Substitute</brief_title>
  <acronym>BME-TARGET</acronym>
  <official_title>Randomized, Double-blind Study for the Treatment of the Bone Marrow Edema:Core Decompression Versus (VS) Subchondral Injections of Autologous BMC VS Subchondral Injections of Bone Substitute</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Istituto Ortopedico Rizzoli</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Istituto Ortopedico Rizzoli</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Randomized, controlled, three-arm, double-blind study : control group, treated with core
      decompression technique VS subchondral plasty by injecting i-FactorTM VS injections of
      autologous BMC.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The clinical trial is a randomized, controlled, three-arm, double-blind study, involving up
      to 120 patients. Eligible subjects will be randomly allocated to one of the three treatment
      groups: control group, treated with core decompression technique, study group 1, treated with
      subchondral plasty by injecting i-FactorTM, and study group 2, treated by injections of
      autologous BMC.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 11, 2016</start_date>
  <completion_date type="Anticipated">March 11, 2024</completion_date>
  <primary_completion_date type="Anticipated">March 11, 2024</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>randomized, controlled, three-arm, double-blind study</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>change of Visual Analogue Scale (VAS) score</measure>
    <time_frame>[Timepoint: Screening, 1 , 3 6, 12, 24 months]</time_frame>
    <description>improvement in VAS score from baseline to follow up</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>International Knee Documentation Committee (IKDC) subjective score</measure>
    <time_frame>[Timepoint: Screening, 1 , 3 6, 12, 24 months]</time_frame>
    <description>improvement in IKDC subjective score from baseline to follow up</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Knee Injury and Osteoarthritis Outcome (KOOS) Score</measure>
    <time_frame>[Timepoint: Screening, 1 , 3 6, 12, 24 months]</time_frame>
    <description>improvement in KOOS score from baseline to follow up</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tegner Activity Level Scale</measure>
    <time_frame>[Timepoint: Screening, 1 , 3 6, 12, 24 months]</time_frame>
    <description>improvement in activity level scale from baseline to follow up</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Bone Marrow Edema</condition>
  <arm_group>
    <arm_group_label>core decompression technique</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The standard surgical technique is the subchondral anterograde drilling, which permit a revascularization of the Bone Marrow Edema (BME) and a reduction of the intramedullary pressure (core decompression).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>bone substitution (i-FactorTM)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>i-FactorTM is a combination of the mineral component of bone (Anorganic Bone Mineral) with a peptide replicating the cell-binding domain of Type-I collagen (P-15). It has been used in bone defects and in spine fusion providing good clinical results. Thus, i-FactorTM could be a valid and efficient bone substitute to treat BMLs with subchondral injections.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>injections of autologous Bone Marrow Concentrate (BMC)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>injections of autologous BMC.</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>autologous bone marrow concentrate</intervention_name>
    <description>injection of autologous bone marrow concentrate</description>
    <arm_group_label>injections of autologous Bone Marrow Concentrate (BMC)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>bone substitute i-FactorTM</intervention_name>
    <description>subchondral injections of i-FactorTM</description>
    <arm_group_label>bone substitution (i-FactorTM)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>core decompression</intervention_name>
    <description>subchondral anterograde drilling</description>
    <arm_group_label>core decompression technique</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Male or female patients between 18 and 75 years;

          2. Symptomatic subchondral bone marrow lesions of femoral condyles (grade â‰¥ 1 according
             to the WORMS MRI score);

          3. Failure after at least two months of a conservative treatment;

          4. Single BME areas involving a single compartment of the knee;

          5. Availability of the patients to participate actively in the rehabilitation protocol
             and follow-up clinic and radiology;

          6. Signature of informed consent.

        Exclusion Criteria:

          1. Patients incapable of discernment;

          2. History of allergy to calcium phosphates;

          3. Patients with malignancies;

          4. Patients with rheumatic diseases;

          5. Patients with diabetes;

          6. Patients suffering of metabolic disorders of the thyroid;

          7. Patients with history of abuse of alcohol, drugs or medication;

          8. Patients with advanced osteoarthritis (Kellgren-Lawrence grade&gt; 3);

          9. Body Mass Index&gt; 35;

         10. BME that involve more than one compartment;

         11. Patients with trauma in the 6 months prior to the intervention. -
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Rizzoli Orthopaedic Institute</name>
      <address>
        <city>Bologna</city>
        <zip>40136</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elizaveta Kon, MD</last_name>
      <phone>0516366567</phone>
      <email>e.kon@biomec.ior.it</email>
    </contact>
    <contact_backup>
      <last_name>Giuseppe Filardo, MD</last_name>
      <phone>0516366501</phone>
    </contact_backup>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 30, 2017</study_first_submitted>
  <study_first_submitted_qc>April 12, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 13, 2017</study_first_posted>
  <last_update_submitted>April 12, 2017</last_update_submitted>
  <last_update_submitted_qc>April 12, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 13, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Istituto Ortopedico Rizzoli</investigator_affiliation>
    <investigator_full_name>Federica Balboni</investigator_full_name>
    <investigator_title>Sub-Investigator</investigator_title>
  </responsible_party>
  <keyword>Bone Marrow Edema</keyword>
  <keyword>Mesenchymal Stem Cells</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Edema</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

